Vitasprint B12 Trinkampullen Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vitasprint b12 trinkampullen

haleon schweiz ag - glutaminum, cyanocobalaminum, dl-phosphoserinum - trinkampullen - pulver: glutaminum 60 mg, mannitolum, pro vitro. lösung: cyanocobalaminum 0.5 mg, dl-phosphoserinum 40 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 1.75 g, natrii hydroxidum, e 219 8 mg, aromatica (himbeer) cum alcohol benzylicus, aqua purificata, ad solutionem pro 7 ml corresp. natrium 10.3 mg. - roborans - synthetika

Bio-Logos Di aggregazione Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bio-logos di aggregazione

alfasigma schweiz ag - glutaminum, l-o-phosphothreoninum, l-o-phosphoserinum, arginini hydrochloridum, hydroxocobalaminum - di aggregazione - i) pacchetto: glutaminum 60 mg, l-o-phosphothreoninum 10 mg, l-o-phosphoserinum 40 mg, arginini hydrochloridum 100 mg, hydroxocobalaminum 0.5 mg, arom.: vanillinum et alia, excipiens annuncio granulatum, g pro 2. ii) pacchetto b: sorbitolum 6 g. - roborans - synthetika

Biovigor sciroppo Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biovigor sciroppo

ibsa institut biochimique sa - hydroxocobalamini chloridum, l-phosphothreoninum, dexfosfoserinum, glutaminum, arginini hydrochloridum - sciroppo - hydroxocobalamini chloridum 0.5 mg, l-phosphothreoninum 10 mg, dexfosfoserinum 40 mg, glutaminum 60 mg, arginini hydrochloridum 100 mg, sorbitolum, aromatica, conserv.: e 211, excipiens ad solutionem pro 10 ml. - ricostituente - synthetika

Bio-Logos Trinklösung Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bio-logos trinklösung

alfasigma schweiz ag - hydroxocobalaminum, l-o-phosphothreoninum, glutaminum, l-o-phosphoserinum, arginini hydrochloridum - trinklösung - hydroxocobalaminum 0.5 mg, l-o-phosphothreoninum 10 mg, glutaminum 60 mg, l-o-phosphoserinum 40 mg, arginini hydrochloridum 100 mg, sorbitolum liquidum non cristallisabile 9 g, e 211 30 mg, natrii hydroxidum, aromatica, aqua ad solutionem pro vitro 10 ml corresp. natrium 8.1 mg. - roborans - synthetika

Dipeptiven Concentrato per soluzione per Infusione Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dipeptiven concentrato per soluzione per infusione

fresenius kabi (schweiz) ag - alaninum, glutaminum - concentrato per soluzione per infusione - alanylglutaminum 200 mg corresp. alaninum 82 mg et glutaminum 134.6 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - nutrizione parenterale - synthetika

Biorganic Geri Gisand Tabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biorganic geri gisand tabletten

gisand ag - betacarotenum, cholecalciferolum, (+)-alfa-tocopherolum, thiamini hydrochloridum, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, nicotinamidum, acidum folicum, panthenolum racemicum, biotinum, acidum ascorbicum, calcium, magnesium, zincum, selenium, bioflavanoida, cholini hydroxidum, cysteinum, methioninum, glutaminum, l-glutathionum - tabletten - vitamina: betacarotenum 3 mg, cholecalciferolum 400 u.i., (+)-alfa-tocopherolum 74 mg, thiamini hydrochloridum 15 mg, riboflavinum 15 mg, pyridoxini hydrochloridum 15 mg, cyanocobalaminum 15 µg, nicotinamidum 4.5 mg, acidum folicum 0.1 mg, panthenolum racemicum 20 mg, biotinum 2.4 µg, acidum ascorbicum 250 mg, mineralia: calcium 50 mg, magnesium 15 mg, zincum 25 mg, selenium 25 µg, alia: ginseng extractum 40 mg corresp. ginsenosidea 1.2 mg, bioflavanoida 10 mg, cholini hydroxidum 25 mg, cysteinum 50 mg, methioninum 50 mg, glutaminum 50 mg, l-glutathionum 10 mg, arom.: ethylvanillinum et alia, excipiens pro compresso. - vitamin- und mineralstoffpräparat bei mangelzuständen im alter - synthetika human

Novocart 3D Transplantatprodukt Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novocart 3d transplantatprodukt

b. braun medical ag - autologous cultured chondrocytes (entspricht 0.75 mio zellen/qcm) - transplantatprodukt - autologous cultured chondrocytes (entspricht 0.75 mio zellen/qcm) 8.25 - 44 mio/11 cm², collagenum ex pericardio bovis (matrize), dulbecco's modified eagle medium /f12 (kommerziell hergestelltes medium mit vertraglich vereinbarter rezeptur), folgende komponenten sind enthalten in den 14.8 ml acidum ascorbicum, chondroitini sulfas natricus, insulinum humanum (emp), diboterminum alfa, albuminum seri humani, glucosum, calcii pantothenas, acidum folicum, inositolum, nicotinamidum, pyridoxini hydrochloridum, riboflavinum, thiamini hydrochloridum, acidum (+)-alpha-liponicum, biotinum, ethylis linolenas, cyanocobalaminum hypoxanthin, thymidin, putrescin, alaninum, arginini hydrochloridum, asparaginum monohydricum, acidum glutamicum, cysteini hydrochloridum monohydricum, acidum glutamicum, histidini hydrochloridum monohydricum, isoleucinum , leucin, lysini hydrochloridum, methioninum, phenylalaninum, prolinum, serinum, threoninum, tryptophanum , thyrosin, valinum, cystinum, glycinum, glutaminum, acidum hydroxyethylpi - chirurgische therapie zur biologischen rekonstruktion artikulärer knorpeldefekte, des kniegelenks mittels matrixgekoppelter autologer knorpelzelltransplantation (mact). - trapianto: gewebeprodukt

Apligraf Apligraf Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

apligraf apligraf

organogenesis switzerland gmbh - umana cheratinociti, fibroblasti umani - apligraf - human keratinocytes 33 %, human fibroblasts 67%, collagena, dulbecco's modified eagle medium, ham's f12, natrii hydrogenocarbonas, calcii chloridum dihydricum, glutaminum, adeninum, acidum selenicum, ethanolaminum, phosphatidylethanolaminum, hydrocortisonum, insulinum humanum (emp) (rekombinates human insulinanalogon), aqua ad iniectabile, pro praeparatione. - apligraf ist indiziert bei erwachsenen patienten für die behandlung von diabetischen fussulzera neuropathischer Ätiologie; apligraf ist indiziert bei erwachsenen patienten für die behandlung von chronischen, nicht-infizierten venösen beinulzera (iaet stadium ii oder iii), welche durch venöse insuffizienz verursacht werden - trapianto: gewebeprodukt

Alofisel 5 Millionen Zellen/ml (eASC) Sospensione iniettabile Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

alofisel 5 millionen zellen/ml (easc) sospensione iniettabile

takeda pharma ag - darvadstrocelum - sospensione iniettabile - suspension: darvadstrocelum 30 mio zellen (easc) in 6 ml, dulbecco's modified eagle medium q.s., albuminum seri humani q.s., glycinum, alanylglutaminum, arginini hydrochloridum, cystinum, histidinum, isoleucinum, leucinum, lysini hydrochloridum, methioninum, phenylalaninum, serinum, threoninum, tryptophanum, tyrosinum, valinum, cholini chloridum, calcii pantothenas, acidum folicum, nicotinamidum, pyridoxini hydrochloridum, riboflavinum, thiamini hydrochloridum, inositolum, calcii chloridum anhydricum, ferri natrii citras, magnesii sulfas desiccatus, kalii chloridum, natrii hydrogenocarbonas, natrii chloridum, natrii dihydrogenophosphas, glucosum, pro praeparatione, phenolsulfonphthaleinum, natrium 70.5 mg pro dosi, kalium <39 mg pro dosi, phenylalaninum 1.2 mg pro dosi. - trattamento della malattia di crohn associati complessi perianalen fistole in pazienti adulti con un attivo o un leichtgradig attivo il morbo di crohn, se le fistole insufficiente in almeno una immunosopressiva o terapia biologica hanno risposto. - trapianto: zelltherapieprodukt

GLUTAMIN FOSFORO Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

glutamin fosforo

laboratorio farmaceutico sit specialita igienico terapeutiche s.r.l. - tonici - tonici